enquiry@dsij.in |+91 9240904920
SENSEX-429.11
72,638.7-0.59%

Godrej Consumer targets core revival as FY27 growth guidance remains intact

Godrej Consumer Products Ltd.

Broker Recommendation:

BUY

Broker: Motilal Oswal Financial Services

02 Sept 2026

Sector: FMCG

Original PDF
Reco. Price

-

CMP

₹867

Target

₹1,150

No Change

-

Investment View and Valuation

Motilal Oswal Financial Services' September 2, 2026 company update retains a BUY recommendation on Godrej Consumer Products (GCPL) with a target price of Rs 1,150, based on 35 times September 2028 estimated EPS.

The broker remains constructive because GCPL is pursuing a core-category revival while scaling new growth engines. However, consistency of execution and delivery against early milestones will be critical.

Strategy and Management Outlook

Management, led by new CEO Aasif Malbari, stated that GCPL is not undertaking a strategic reset. Instead, the company plans to improve execution of its existing strategy, scale successful products faster and address underperforming businesses through granular country-, category- and market-level plans.

Management acknowledged that historical performance has fallen short of aspirations. Organic volume growth was about 4% in both India and the consolidated business over the past five years, while organic sales growth was about 7% in India and 6% on a consolidated basis. EBITDA growth was about 6%, with flat core-category revenue and profitability pressure representing key structural weaknesses.

GCPL nevertheless believes it now has a simplified operating structure, a stronger balance sheet and capital-allocation framework, and multiple growth pilots.

Growth Guidance and Financial Outlook

GCPL retained its FY27 guidance for high-single-digit standalone volume growth and double-digit consolidated revenue and EBITDA growth. Consolidated revenue and EBITDA grew 18% and 15%, respectively, in Q1 FY27.

Management also outlined a medium-term ambition for mid-teens consolidated revenue and profit growth, with sustained profit growth serving as the measure of structural outperformance. Motilal Oswal forecasts revenue and EBITDA CAGRs of 13% and 14%, respectively, over FY26 to FY29E.

Metric FY26 FY27E FY29E
Total revenue Rs 15,180 crore Rs 17,830 crore Rs 21,770 crore

The segment estimates indicate that growth will be driven principally by India and the GAUM region.

Core-Category Revival and Growth Engines

Core revival is the immediate priority because the first six categories account for about 90% of revenue. GCPL aims to lift these categories to at least industry-level growth through sharper innovation and execution, while portfolio expansion is expected to provide incremental growth.

The company is building an approximately Rs 150 crore R&D centre intended to double R&D capacity. G-Lab, pet care and entry into new categories have been identified as portfolio-transformation levers.

  • Household insecticides: Management sees a structural opportunity, citing penetration rising from about 65% to 80% and volumes compounding at about 15%.
  • Soaps and skin cleansing: These categories offer scope for share gains.
  • Hair colour: The category has an upgrade opportunity because about two-thirds of consumers still use traditional formats.
  • Hair care: Management continues to view this as a long-duration opportunity.
  • Fragrances: Corrective action is expected after execution and RCCL-acquisition integration issues.
Large_Rhino.webp

Building Wealth Through Established Businesses

Large-cap companies often form the foundation of a resilient portfolio. DSIJ's Large Rhino focuses on fundamentally strong businesses selected through detailed research for long-term investors.

Near-Term Profitability and Channel Inventory

Near-term profitability faces pressure as GCPL plans to remove Rs 125 crore to Rs 150 crore of India distributor inventory over the next three quarters. This is expected to reduce general-trade inventory from about 20 days to about 10 days.

Management regards the inventory reduction as a channel correction rather than a demand issue. Lower inventory is expected to improve working-capital efficiency and enable more off-take-led execution.

International inventory remains healthy. Restructuring in Africa, the Middle East and the Americas is largely complete, allowing increased focus on hair care, household insecticides, hair colour and other winning categories.

Investment, Simplification and Capital Allocation

The company expects approximately Rs 200 crore of front-loaded investment over the next 12 months in R&D, global go-to-market and digital capabilities. This includes approximately Rs 150 crore of R&D capex, with an expected two-to-three-year payback.

Simplification is 70% to 80% complete. Further benefits are expected from technology, asset utilisation and operating productivity over the next 1.5 to 2 years. Major capex projects should largely conclude in FY27, with capex intensity expected to moderate from FY28.

Management said that M&A will be selective, increasingly India-focused and subject to three requirements: a clear right to win, attractive unit economics and meaningful potential to accelerate growth.

Download Original Research Report

Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.